Asia Spotlight: 2012 Korea Outlook – More Tough Times Seen For Pharma As Grip Tightens On Irregular Business Deals and Price Cuts
Executive Summary
A crack down on rebates and new price cuts will force Korean pharma companies to shift focus to R&D in 2012 and seek out more co-promotion deals with Big Pharma.